Weiwei Tan

7PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 10, 2026
Population Pharmacokinetics and Exposure-Response Analyses of Vepdegestrant, a First-in-Class PROteolysis-TArgeting Chimera Estrogen Receptor Degrader.

|Jun 18, 2026
Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants.

|Feb 18, 2026
Effect of carbamazepine on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader, in healthy adults.

Hechuan Wang, Jennifer A Winton, Kyle T Matschke

|Aug 18, 2025
Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants.

Derek Z Yang, Li Zhou, Jennifer A Winton

|Jun 13, 2021
Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations.

Jerry Li, Dana Nickens, Keith Wilner

|Dec 21, 2019
Evaluation of the potential effect of dacomitinib, an EGFR tyrosine kinase inhibitor, on ECG parameters in patients with advanced non-small cell lung cancer.

Weiwei Tan, Nagdeep Giri, Susan Quinn

Pageof 2

Frequent Collaborators

2 joint publications

Lana Tran

1 joint publications

Hechuan Wang

1 joint publications

Alexandre Stouffs

1 joint publications

Joanna C Masters